2.04
Aytu Biopharma Inc (AYTU) 最新ニュース
Aytu BioPharma, Inc. Stock Price Today | AYTU Live Chart & News - Traders Union
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? - Zacks Investment Research
Aytu BioPharma (NasdaqCM:AYTU) Stock Forecast & Analyst Predictions - Simply Wall Street
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
AYTU|Aytu Biopharma Inc|Price:2.230|Chg%:+0.105 - TradingKey
Aytu BioPharma Narrows Fiscal 2026 Loss to $14.3 Million as EXXUA Debuts - Minichart
Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates - Zacks Investment Research
EXXUA prescriptions jump as Aytu BioPharma (AYTU) posts Q4 and full-year results - Stock Titan
A depression drug generated $3.9 million in its first full quarter - Stock Titan
When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Turn A Profit? - simplywall.st
AYTU Q2 2026 Earnings: Loss Per Share Misses by 1.88% as Stock Holds UpDividend Cut Risk - vinanet.vn
AYTU | AYTU BioPharma, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Aytu (AYTU) Q2 2026 Earnings: EPS Misses Its Estimate; Closing Move: The Market Reaction Is Muted in the Current UpdatePerformance Review - vinanet.vn
Aytu BioPharma (AYTU) investor and foundation each report 4.99% beneficial stake - Stock Titan
Aytu BioPharma (AYTU) Slips 1.7% to $2.36 as Biotech Volatility PersistsRisk Parity Rebalance - vinanet.vn
Aytu BioPharma (AYTU) Slips 1.7% to $2.36 as Biotech Volatility PersistsZigzag Correction - dars.gov.et
AYTU Q2 2026 Earnings: Narrow EPS Miss Slightly Wider Than Expected, Shares Rise 1.69%Earnings Expansion Phase - vinanet.vn
Aytu Biopharma Inc (AYTU) Stock News Today - TradingKey
Aytu BioPharma, Inc. (0A8M.L) valuation measures and financial statistics - Yahoo Finance Australia
Aytu Biopharma Inc (AYTU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CNSY Stock Price and Chart — NASDAQ:CNSY - tradingview.com
Aytu BioPharma (AYTU) Climbs 3.72% to $2.23 — Approaching Key ResistanceBreadth Thrust - vinanet.vn
Aytu BioScience Inc (0A8M) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Aytu Biopharma Inc (AYTU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aytu Biopharma Inc (AYTU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aytu BioPharma Market Sentiment - Benzinga España
Aytu Biopharma Inc (AYTU) Cash Flow - TradingKey
Aytu Biopharma Inc (AYTU) Balance Sheet - TradingKey
AYTU|Aytu Biopharma Inc|Price:2.107|Chg%:+0.046 - TradingKey
AYTU|Aytu Biopharma Inc|Price:2.160| - TradingKey
Aytu Biopharma Inc (AYTU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aytu Biopharma Inc (AYTU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aytu Biopharma Inc (AYTU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aytu Biopharma Inc (AYTU) Income Statement - TradingKey
AYTU Q2 2026 Earnings: EPS Misses Estimates by Nearly 2%, Stock Holds SteadyProfit Announcement - vinanet.vn
Aytu BioPharma, Inc. Revenue Breakdown – NASDAQ:AYTU - TradingView
AYTU Q2 2026 Earnings: EPS Slightly Misses Estimates with Minimal SurprisePerformance Review - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterCore Business Growth - vinanet.vn
Aytu BioPharma (AYTU) Edges Higher as Stock Tests Key ResistanceOvernight Profile - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates Amid No Revenue; Stock Edges HigherCapex Guidance - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Consensus, Stock Falls SlightlyRevenue Guidance Update - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates, Stock DeclinesNet Income Trends - vinanet.vn
New Strong Sell Stocks for July 16th - Yahoo Finance
AYTU Q2 2026 Earnings: EPS Misses Estimates, Shares Edge HigherPost-Earnings Drift - vinanet.vn
AYTU Q2 2026 Earnings: EPS Misses Estimates Amid Narrow Loss; Stock Edges HigherPost-Earnings Drift - vinanet.vn
Aytu BioPharma (AYTU) Edges Higher, Testing Key Resistance LevelsGap Fill Strategy - dars.gov.et
Aytu BioPharma (AYTU) Edges Higher, Testing Key Resistance LevelsBollinger Walk - DonanımHaber
Aytu BioPharma (AYTU) Edges Higher, Testing Key Resistance LevelsRVOL Breakout - dars.gov.et
AYTU Q2 2026 Earnings: EPS Miss Slightly Wider Than Expected; Stock Rises 2.74% Amid Strategic ReviewEarnings Beat Streak - dars.gov.et
AYTU Q2 2026 Earnings: EPS Misses Estimates Slightly, Stock Edges HigherNet Profit Margin - dars.gov.et
大文字化:
|
ボリューム (24 時間):